Luminescent method of detecting soluble guanylate cyclase

Details Luminescent method of detecting soluble guanylate cyclase Luminescent method of detecting soluble guanylate cyclase

2005-07-05

2005-07-05

Gitomer, Ralph (Department: 1651)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving luciferase

C435S015000

Reexamination Certificate

active

06913898

ABSTRACT:
The invention relates to methods for detecting a soluble guanylate cyclase whose heme iron is in the trivalent oxidation state, and to methods for finding chemical substances which stimulate the activity of a soluble guanylate cyclase when the heme iron of at least part of this soluble guanylate cyclase is oxidized to the trivalent state and also to diagnostic aids or kits for detecting a soluble guanylate cyclase with trivalent heme iron. Further, the invention relates methods for detecting a soluble guanylate cyclase lacking a heme group, and to methods for finding chemical substances which stimulate the activity of a soluble guanylate cyclase lacking a heme group.

REFERENCES:
patent: 5618665 (1997-04-01), Lurie et al.
patent: 6335334 (2002-01-01), Schindler et al.
patent: 6500631 (2002-12-01), Schindler et al.
patent: 198 37 015 (2000-02-01), None
patent: 876715 (1981-10-01), None
patent: WO 00/02851 (2000-01-01), None
Olesen et al., “Characterization of NS 2028 as a Specific Inhibitor of Soluble Guanylyl Cyclase”, British Journal of Pharmacology, vol. 123, pp. 299-309 (1998).
Ignarro et al., “Selective Alterations in Responsiveness of Guanylate Cyclase to Activation by Nitroso Compounds during Enzyme Purification”, Biochemica et Biophysica Acta, vol. 673, pp. 394-407 (1981).
Gupte et al., “NADPH and Heme Redox Modulate Pulmonary Artery Relaxation and Guanylate Cyclase Activation by NO”, Am. J. Physiol., vol. 277, pp. L.1124-L1132 (1999).
Schrammel et al., “Characterization of 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one as a Heme-Site Inhibitor of Nitric Oxide-Sensitive Guanylyl Cyclase”, Molecular Pharmacology, vol. 50, pp. 1-5 (1996).
Makino et al., “EPR Characterization of Axial Bond in Metal Center of Native and Cobalt-substituted Guanylate Cyclase”, The Journal of Biological Chemistry, vol. 274, No. 12, Issue of Mar. 19, pp. 7714-7723 (1999).
European Search Report of Apr. 20, 2001.
Derwent Abstract of DE 198 37 015.
Foerster, John; Harteneck, Christian; Malkewitz, Jürgen; Schultz, Günter; and Koesling, Doris; “A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of α1and β1subunits,” Eur. J. Biochem., 240:380-386 (1996).
Giuili, Galicia; Scholl, Ute; Bulle, Frédérique; and Guellaën, Georges, “Molecular clonging of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain,” FEBS LETTERS, 304(1):83-88 (Jun. 1992).
Humbert, Peter; Niroomand, Feraydoon; Fischer, Gabriela; Mayer, Bernd; Koesling, Doris; Hinsch, Klaus-Dieter; Schultz, Günter; and Böhme, Eycke, “Preparation of Soluble Guanylyl Cyclase from Bovine Lung by Immunoaffinity Chromatography,” Methods in Enzymology, 195:384-391 (1991).
Ignarro, Louis J., “Regulation of Cytosolic Guanylyl Cyclase by Porphyrins and Metalloporphyrins,” Advances in Pharmacology, 26:35-65 (1994).
Koesling, D. and Friebe, A., “Soluble Guanylyl Cyclase: Structure and Regulation,” Reviews of Physiology Biochemistry and Pharmacology, 135:42-64 (1999).
Moro, Maria A.; Russell, Rachel J.; Cellek, Selim ; Lizasoain, Ignacio ; Su, Yunchao ; Darly-Usmar, Victor M. ; Radomski, Marek W.; and Moncada, Salvador, “cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the Soluble Guanylyl Cyclase,” Proc. Natl. Acad. Sci. USA, 93:1480-1485 (Feb. 1996).
Nakane, Masaki; Arai, Kazuko; Saheki, Shuichi; Kuno, Takayoshi; Buechler, Wolfgang; and Murad, Ferid, “Molecular Cloning and Expression of cDNAs Coding for Soluble Guanylyl Cyclase from Rat Lung,” J. of Biological Chemistry, 265(28):16841-16846 (Oct. 5, 1990).
Vesely, D.L., “B complex vitamins activate rat Guanylate Cyclase and increase cyclic GMP levels”, European Journal of Clinical Investigation, 15:258-262 (1985).
Yuen, Peter S. T.; Potter, Lincoln, R.; and Garbers, David L., “A New Form of Guanylyl Cyclase is Preferentially Expressed in Rat Kidney,” Biochemistry, 29:10872-10878 (1990).
Stone J., “Spectral and Ligand Binding Properties of an Unusual Hemoprotein, The Ferric Form of Soluble Guanylate Cyclase.”, Biochemistry, 1996, 35(10), pp. 3258-3262.

Affiliated with

Also associated with

Rating

Luminescent method of detecting soluble guanylate cyclase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Luminescent method of detecting soluble guanylate cyclase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Luminescent method of detecting soluble guanylate cyclase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3428216